The data suggested that plasma ISG15 levels were higher in SCA1 patients than in normal controls at the initial sampling time point and at the time point when the plasma ISG15 level was highest among multiple samplings from a SCA1 patient (Fig. 7d). This evidence concerns the gene ISG15 and spinocerebellar ataxia type 1.